Immunize.org's Dr Kelly Moore says that without clear surveillance data on RSV, particularly on hospitalizations, clinicians may hesitate to commit office resources to administration.

Your daily dose of clinical news you may have missed.

Findings highlight the need to develop strategies to improve weight management in primary care, according to study authors.

Bayer's investigational FXIa inhibitor is currently being studied in a large-scale phase 3 development program expected to enroll more than 27 000 participants.

Brixadi is the first and only long-acting buprenorphine injectable that is available in both weekly and monthly doses.

The AAFP and other national medical groups endorsed the warning from Surgeon General Murthy that social media is fueling the mental health crisis among young Americans.

A recent CDC report showed that approximately 20% of Americans experienced chronic pain in 2021 and certain groups were most vulnerable. Details in our new slideshow.

Low awareness of RSV in adults and misperceptions about the goal of vaccination aren't new challenges, says Kelly Moore, MD, MPH, Immunize.org president and CEO.

Your daily dose of clinical news you may have missed.

In a unique pharmacodynamic study, nalmefene demonstrated rapid reversal of respiratory depression from the synthetic opioid remifentanil and sustained duration of action.

Medical director of the NFID William Schaffner, MD, discusses the research behind the FDA's decision to approve the first-ever RSV vaccine.

Efficacy of the daily pill met the standard now established by the once-weekly injection of 15% loss of baseline bodyweight in adults with overweight or obesity, says Novo Nordisk.

Your daily dose of clinical news you may have missed.

A nationally recognized obesity expert discusses mental health in women with obesity.

The findings contradict published clinical guidelines that warn against use of estrogen-containing birth control by women who have migraine with aura.

Findings of the BOREAS trial of patients with COPD and type 2 inflammation make dupilumab the first biologic to significantly reduce exacerbations by 30% vs placebo.

Immunize.org president and CEO Kelly Moore, MD, MHP, describes the holistic view the ACIP will take of the virus, the vaccine, and the overall economics of the immunization.

Your daily dose of clinical news you may have missed.

Statin therapy initiated within 1 year of diagnosis of atrial fibrillation reduced the risk of ischemic stroke or systemic embolism by nearly 20%.

Findings also showed that between 1990 and 2019, the global number of ischemic stroke deaths rose from 2 million to 3 million.

The Pfizer vaccine RSVpreF administered to pregnant people was judged by the advisory committee to be effective at preventing RSV in infants from birth to 6 months.

Kelly Moore, MD, MPH, says the public health community is relieved by the FDA's approval and excited at "the chance to finally do something about the disease."

Eden Miller, DO, highlights a lack of knowledge in both the patient and the prescriber as a barrier to effective use of BGM technology in diabetes, as well as the need for personalized care for patients.

Elizabeth Holt, MD, FACE, provides an overview of a study on patients with diabetes using the OneTouch Verio Flex meter, a blood glucose meter (BGM) and OneTouch Reveal, a diabetes-management digital app, in tandem.

Your daily dose of clinical news you may have missed.